Similar articles

• Ketoconazole therapy for hormonally refractive metastatic prostate cancer.

  Johnson DE, Babaian RJ, von Eschenbach AC, Wishnow KI, Tenney D. Johnson DE, et al. Urology. 1988 Feb;31(2):132-4. doi: 10.1016/0090-4295(88)90036-2. Urology. 1988. PMID: 3341098
• Ketoconazole high dose (H.D.) in the management of hormonally pretreated patients with progressive metastatic prostate cancer.

  Debruyne FM, Witjes FA. Debruyne FM, et al. Prog Clin Biol Res. 1987;243A:301-13. Prog Clin Biol Res. 1987. PMID: 3659003
• [Prostate carcinoma and its management].

  Ruutu M. Ruutu M. Duodecim. 1989;105(3):287-92. Duodecim. 1989. PMID: 2649362 Review. Finnish. No abstract available.
• [New hormonal treatments of metastatic prostatic cancer. Review of the literature].

  Dubost JJ, Sauvezie B, Ristori JM, Thevenet JP, Rampon S. Dubost JJ, et al. Rev Rhum Mal Osteoartic. 1985 Oct;52(10):577-85. Rev Rhum Mal Osteoartic. 1985. PMID: 3909364 Review. French. No abstract available.
• Controversies in the treatment of carcinoma of the prostate.

  el-Mahdi AM, Kuban DA. el-Mahdi AM, et al. Compr Ther. 1986 Aug;12(8):33-6. Compr Ther. 1986. PMID: 3742995 No abstract available.